SEC Form 4 · accession 0001209191-17-060914
STERIS plc · STE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Adam Zangerle
Officer — VP, Gen Counsel, and Sec.
Period of report
Nov 14, 2017
Accepted (ET)
Nov 15, 2017 · 4:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001624899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, 10 pence par valueF1 | Nov 14, 2017 | M | 1,750 | $36.09 | A | 29,596 | D | |
| Ordinary Shares, 10 pence par value | Nov 14, 2017 | S | 1,750 | $88.00 | D | 27,846 | D | |
| Ordinary Shares, 10 pence par valueF2 | Nov 14, 2017 | M | 1,900 | $29.94 | A | 29,746 | D | |
| Ordinary Shares, 10 pence par valueF3 | Nov 14, 2017 | S | 1,900 | $88.00 | D | 27,846 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $36.09 | Nov 14, 2017 | M | 1,750 | D | — | May 31, 2021 | Ordinary Shares | 3,500 | 1,750 | D |
| Employee Stock Option (right to buy)F5 | $29.94 | Nov 14, 2017 | M | 1,900 | D | — | May 30, 2022 | Ordinary Shares | 1,900 | 0 | D |
Explanation of responses
- F1This exercise and sale of a total of 1,750 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 15, 2017.
- F2This exercise and sale of a total of 1,900 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 15, 2017.
- F317,752 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,252 on May 30, 2018; 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020 and 6,000 on June 1, 2021.
- F4This option to purchase 3,500 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 3,500 STERIS common shares for $36.09 per share, subject to the same terms and conditions as the original STERIS Corporation stock option.
- F5This option to purchase 3,800 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 3,800 STERIS common shares for $29.94 per share, subject to the same terms and conditions as the original STERIS Corporation stock option.